View Older Stories View More Recent Stories

Dec 13, 2021 05:09AM Global Blood Therapeutics (GBT) Reports Positive New Data on Oxbryta
Dec 12, 2021 09:00AM GBT Presents Positive New Data on Oxbryta® (voxelotor) in Patients with Sickle Cell Disease at ASH Annual Meeting and Exposition
Dec 9, 2021 08:00AM GBT Announces New Employment Inducement Grants
Dec 2, 2021 08:00AM GBT Supports the ASH Research Collaborative’s Data Hub Sickle Cell Disease Program
Dec 2, 2021 08:00AM GBT Supports the ASH Research Collaborative's Data Hub Sickle Cell Disease Program
Nov 24, 2021 08:00AM GBT Announces Participation at the 4th Annual Evercore ISI HealthCONx Conference
Nov 12, 2021 08:00AM GBT Announces Participation in Upcoming Investor Conferences
Nov 8, 2021 08:00AM GBT Announces New Employment Inducement Grants
Nov 4, 2021 04:05PM GBT Reports Third Quarter 2021 Financial Results
Nov 4, 2021 09:05AM GBT Announces Six Data Presentations on Sickle Cell Disease at Upcoming 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Nov 1, 2021 08:00AM GBT Wins Prestigious Prix Galien USA Award for Oxbryta® (voxelotor)
Oct 28, 2021 08:00AM GBT to Announce Third Quarter 2021 Financial Results on Thursday, November 4
Oct 7, 2021 09:29AM Pre-Open Stock Movers 10/07: (CEI) (RKLB) (APP) Higher; (OSMT) (LW) (DNA) Lower (more...)
Oct 7, 2021 08:00AM GBT Announces New Employment Inducement Grants
Oct 6, 2021 06:01PM After-Hours Stock Movers 10/06: (CEI) (RKLB) (APP) Higher; (OSMT) (DNA) Lower (more...)
Sep 20, 2021 08:00AM GBT Announces Participation at the Cantor Global Healthcare Conference
Sep 14, 2021 11:00AM GBT Establishes The GBT Foundation to Improve the Health and Well-being of Underserved Patient Communities Around the World
Sep 14, 2021 11:00AM GBT Establishes The GBT Foundation to Improve the Health and Well-being of Underserved Patient Communities Around the World
Sep 9, 2021 08:00AM GBT Announces New Employment Inducement Grants
Sep 8, 2021 05:05PM GBT and Sickle Cell Disease Association of America to Host 10th Annual Sickle Cell Disease (SCD) Therapeutics Conference
Sep 7, 2021 08:01AM Global Blood Therapeutics (GBT) Announces U.S. FDA Accepts for Priority Review sNDA for Oxbryta for Treatment of Sickle Cell Disease in Children Ages 4 to 11
Sep 7, 2021 08:00AM U.S. FDA Accepts for Priority Review Supplemental New Drug Application for Oxbryta® (voxelotor) for the Treatment of Sickle Cell Disease in Children Ages 4 to 11
Sep 2, 2021 08:00AM GBT Announces Participation in Upcoming Investor Conferences
Aug 12, 2021 08:00AM GBT Announces New Employment Inducement Grants
Aug 4, 2021 08:00AM GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
Aug 3, 2021 04:05PM GBT Reports Second Quarter 2021 Financial Results
Jul 27, 2021 08:00AM GBT to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
Jul 22, 2021 07:00AM GBT Provides Regulatory and Pipeline Updates in Sickle Cell Disease (SCD)
Jul 9, 2021 08:00AM GBT Announces New Employment Inducement Grants
Jun 15, 2021 08:00AM GBT Awards $450,000 in ACCEL Grants to Improve Access to Care in Sickle Cell Disease
Jun 14, 2021 07:00AM Global Blood Therapeutics' (GBT) Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK
Jun 14, 2021 07:00AM GBT’s Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK
Jun 14, 2021 07:00AM GBT’s Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK
Jun 11, 2021 03:05AM New Data Supporting the Potential Use of Oxbryta® (voxelotor) in Children Ages 4 to 11 Years with Sickle Cell Disease Presented at European Hematology Association 2021 Virtual Congress
Jun 11, 2021 03:00AM New Data Supporting the Potential Use of Oxbryta® (voxelotor) in Children Ages 4 to 11 Years with Sickle Cell Disease Presented at European Hematology Association 2021 Virtual Congress
Jun 4, 2021 08:00AM GBT Announces New Employment Inducement Grants
Jun 1, 2021 08:00AM GBT Announces Participation at the Goldman Sachs 42nd Annual Global Healthcare Conference
May 12, 2021 10:07AM Global Blood Therapeutics (GBT) Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:00AM GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:00AM GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress
May 7, 2021 08:00AM GBT Announces New Employment Inducement Grants
May 6, 2021 08:00AM GBT Announces Participation in Upcoming Investor Conferences
May 5, 2021 04:05PM GBT Reports First Quarter 2021 Financial Results
May 4, 2021 08:00AM GBT and Sickle Cell Disease Association of America Kick Off “Lift Every Voice to Shine the Light on Sickle Cell” Spoken Word Contest in Honor of World Sickle Cell Day 2021
Apr 28, 2021 07:00AM GBT to Announce First Quarter 2021 Financial Results on Wednesday, May 5, 2021
Apr 8, 2021 06:28AM Global Blood Therapeutics (GBT) 72-Week Results from Phase 3 HOPE Study of Oxbryta Tablets Published in The Lancet Haematology
Apr 8, 2021 03:00AM Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sic
Apr 8, 2021 03:00AM Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sic
Apr 5, 2021 08:00AM GBT Announces New Employment Inducement Grants
Mar 18, 2021 07:00AM GBT Appoints Alexis A. Thompson, M.D., M.P.H., to Board of Directors
View More Recent Stories View Older Stories